Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

PHASE4CompletedINTERVENTIONAL
Enrollment

152,723

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2007

Conditions
PneumoniaAcute Respiratory Disease
Interventions
BIOLOGICAL

23-valent pneumococcal vaccine

randomization, based upon a random-number (block design) double-blind enrollment sequence. 1:1 ratio.

BIOLOGICAL

Placebo

Trial Locations (5)

Unknown

Marine Recruit Training Center, San Diego

Naval Recruit Training Center, Great Lakes

Army Recruit Training Center, Fort Leonard Wood

Army Recruit Training Center, Fort Jackson

Marine Recruit Training Center, Parris Island

Sponsors
All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

lead

Naval Health Research Center

FED